Root Financial Partners’s Artiva Biotherapeutics ARTV Stock Holding History

Root Financial Partners’s Portfolio ARTV Stock Details ARTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7	Buy	+1	New	+$10	﹤0.01%	3809

Other funds holding ARTV

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Root Financial Partners's ARTV Position: Q3 2026 in Review

Root Financial Partners opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3809 among its holdings.

11 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

Root Financial Partners held 1 share of Artiva Biotherapeutics worth $7 as of Q3 2026.
Artiva Biotherapeutics was a new Root Financial Partners position in Q3 2026.
Artiva Biotherapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3809 holding.
11 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.